MALLORY HARVEY: Open Payments
NPI 1932960325 · HUDSON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$951 in 47 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,196 · 2025 $951
Food & beverage: $951
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $175 |
| Regeneron Healthcare Solutions, Inc. | 5 | $147 |
| ABBVIE INC. | 9 | $140 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $122 |
| UCB, Inc. | 4 | $85 |
| Arcutis Biotherapeutics, Inc. | 4 | $69 |
| Janssen Biotech, Inc. | 2 | $49 |
| Incyte Corporation | 2 | $39 |
| Galderma Laboratories, L.P. | 2 | $33 |
| GENZYME CORPORATION | 1 | $25 |
Products named: DUPIXENT, COSENTYX, ILUMYA, SKYRIZI, Bimzelx, Zoryve, RINVOQ, TREMFYA.
Industry payments across FL — which companies pay providers there.
